Loading...

Genomma Lab Internacional, S.A.B. de C.V.

GNMLF•PNK
Healthcare
Drug Manufacturers - Specialty & Generic
$1.08
$0.00(0.00%)
U.S. Market opens in 14h 21m

Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) Stock Overview

Explore Genomma Lab Internacional, S.A.B. de C.V.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap1.1B
P/E Ratio18.58
EPS (TTM)$0.09
ROE0.11%
Fundamental Analysis

AI Price Forecasts

1 Month$0.76
3 Months$0.66
1 Year Target$0.80

GNMLF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 71.62, suggesting the stock is in an overbought condition. Our forecasting models predict significant price movements, with a 12-month target of $0.80.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 18.58 and a market capitalization of 1.1B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
8.00%
3-Month Change
1.89%
6-Month Change
15.53%
Year-to-Date (YTD) Change
1.89%
1-Year Change
-24.48%
3-Year Change
28.57%
5-Year Change
8.00%
All-Time (Max) Change
-44.62%

Contact Information

https://www.genommalab.com
52 55 5081 0000
Av. Antonio Dovalí Jaime no.70, Mexico City, DF, 01210

Company Facts

1,605 Employees
IPO DateMay 4, 2012
CountryMX
Actively Trading

Frequently Asked Questions